B
BLAC
vs
S&P 500
S&P 500
Over the past 12 months, BLAC has underperformed S&P 500, delivering a return of -74% compared to the S&P 500's +13% growth.
Stocks Performance
BLAC vs S&P 500
Performance Gap
BLAC vs S&P 500
Performance By Year
BLAC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bellevue Life Sciences Acquisition Corp
Glance View
Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.
